" "
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Erin O’Shea Named Vice President and Chief Scientific Officer at HHMI

Published: Monday, December 03, 2012
Last Updated: Sunday, December 02, 2012
Bookmark and Share
O’Shea to begin her new duties part-time in January 2013 and transition to full-time in July 2013.

The Trustees of the Howard Hughes Medical Institute have elected Professor Erin K. O’Shea, Ph.D., now a Howard Hughes Medical Institute investigator at Harvard University, as Vice President and Chief Scientific Officer.

A member of both the National Academy of Sciences and the American Academy of Arts and Sciences, O’Shea is regarded as a leader in the fields of gene regulation, signal transduction, and systems biology.

Her research focuses on the way cells sense changes in their environment and respond appropriately, work that has implications for understanding cancer and other diseases.

For the last seven years, O’Shea has served as Director of the Harvard Faculty of Arts and Sciences Center for Systems Biology, an interdisciplinary research center that brings together people from the physical and life sciences to solve problems in biology.

In addition, O’Shea is the Paul C. Mangelsdorf Professor of Molecular and Cellular Biology and Chemistry and Chemical Biology at Harvard.

She was recruited to Harvard in 2005 from the University of California, San Francisco (UCSF), where she had been an HHMI investigator since 2000.

“HHMI scientists are among the most creative and accomplished biomedical researchers in the world. Erin’s passion for science, her scholarship, her breadth of scientific interests, and her exceptional skills as a mentor and teacher make her the ideal person to lead our scientific programs,” said HHMI President Robert Tjian, Ph.D., in making the announcement.

O’Shea will lead the Institute’s flagship HHMI Investigator Program, in which leading scientists and their staff conduct research in HHMI laboratories across the United States.

At HHMI, she will oversee a broad scientific portfolio, which includes programs that support early career scientists in the United States and abroad, and initiatives that foster innovative, collaborative research.

O’Shea will also be responsible for identifying new opportunities that capitalize on the Institute's expertise in biomedical research and science education.

“I was attracted to this position because it provides an opportunity to have a positive and lasting influence on research on the national and international level, as well as to work with colleagues to elevate the importance and quality of science education,” said O’Shea.

O’Shea continued, “I see opportunities to identify and support great scientists, to develop and test programs that can serve as models which can be expanded and adopted by others, and to support the development and dissemination of transformative technologies.”

O’Shea received her undergraduate degree in biochemistry from Smith College and her Ph.D. degree in chemistry from the Massachusetts Institute of Technology, for work done with Peter Kim, who is now president of Merck Research Laboratories. She carried out postdoctoral research with Robert Tjian at the University of California, Berkeley, and with the late Ira Herskowitz at UCSF.

Her honors include the National Academy of Sciences Award in Molecular Biology, a David and Lucile Packard Foundation Fellowship, a Presidential Faculty Fellow Award, the American Society for Cell Biology-Promega Early Career Life Science Award, and the Irving Sigal Young Investigator Award from the Protein Society.

O’Shea will continue to maintain her lab at Harvard, where she conducts research on several broad areas: understanding how regulatory networks encode and decode information to control the production of genes; and investigating the function and mechanism of oscillation of a three-protein circadian clock found in bacteria.

In a new project, she is studying the mechanism of drug action, making use of a human cell line amenable to loss-of-function genetic approaches.

O’Shea succeeds Jack E. Dixon, Ph.D., who has led HHMI’s scientific programs since 2007. In 2012, Dixon announced his intention to retire as vice president and chief scientific officer.

Dixon will return to the University of California, San Diego in 2013 to continue his longstanding research on protein tyrosine phosphatases - biochemical “master control switches” that regulate much of the activity in living cells.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A Crisper View of DNA-Snipping Enzyme
HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
Saturday, February 08, 2014
Spontaneous Mutations Play a Key Role in Congenital Heart Disease
New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Monday, May 13, 2013
A New View of Transcription Initiation
Reading the human genome.
Monday, March 04, 2013
Search for Epigenetic Decoder in Brain Cells Leads Scientists to Rett Syndrome
New analysis suggests that MeCP2 recognizes 5hmC in the brain and facilitates activation of the genes.
Monday, December 31, 2012
Scientists Find Mechanism that Triggers Immune Responses to DNA
HHMI scientists have discovered the molecular pathway outside a cell’s nucleus in the cytosol.
Monday, December 24, 2012
Susan Desmond-Hellmann Elected as HHMI Trustee
Desmond-Hellmann becomes one of 11 Trustees of the Institute.
Thursday, November 08, 2012
Autism Gene Screen Highlights Protein Network for Howard Hughes Medical Institute Scientists
Over the past decade, scientists have added many gene mutations to the list of potential risk factors for autism spectrum disorders -- but researchers still lack a definitive explanation of autism’s cause.
Thursday, April 05, 2012
Scientists Trace Origin of Recent Cholera Epidemic in Haiti
The finding supports the notion that the cholera bacteria fueling the outbreak arrived on the island via recent visitors.
Friday, December 10, 2010
New Tool Illuminates Connections Between Stem Cells and Cancer
HHMI researchers have a new tool to understand how cancers grow - and with it a new opportunity to identify novel cancer drugs.
Monday, February 22, 2010
Crash-Test Reveals DNA Traffic Control
Researchers have discovered that when DNA-copying enzymes run head-on into oncoming traffic, they kick the obstacles out of their way.
Friday, January 29, 2010
Mutations in Different Cells Cooperate to Set the Stage for Cancer
HHMI researchers have shown that distinct cancer-causing mutations in neighboring cells can cooperate to produce tumors.
Friday, January 15, 2010
Scientists Identify new Genetic Culprit for Intellectual Disability
Researchers link the girls’ intellectual disability to a change in a single “letter” in the TRAPPC9 gene.
Friday, December 18, 2009
Scientists Identify New Genetic Culprit for Intellectual Disability
HHMI researchers identified a genetic mutation that plays a role in intellectual disability.
Monday, December 14, 2009
Sticklebacks Hone Defenses through Small DNA Deletions
A single genetic adjustment is enough to help a small fish make a big change, HHMI researchers find.
Friday, December 11, 2009
Researchers Identify Gene that Spurs Deadly Brain Cancer
HHMI researchers identify a new factor necessary for the development of many forms of medulloblastoma.
Friday, December 04, 2009
Scientific News
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
The Spice of Life
Scientists discover important genetic source of human diversity.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH-funded study could lead to new tick control methods.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!